Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10868)
All Articles published online
|
Publishing Process of This Article
|
Mar 14, 2019 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Foster AJ, Smyth M, Lakhani A, Jung B, Brant RF, Jacobson K. Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn’s disease patients. World J Gastroenterol 2019; 25(10): 1266-1277 [PMID: 30886509 DOI: 10.3748/wjg.v25.i10.1266] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i10/1266.htm |
| Number | Citing Articles |
| 1 |
Egle Kvedaraite. Neutrophil–T cell crosstalk in inflammatory bowel disease. Immunology 2021; 164(4): 657 doi: 10.1111/imm.13391
|
| 2 |
Dan Turner, Amanda Ricciuto, Ayanna Lewis, Ferdinando D’Amico, Jasbir Dhaliwal, Anne M. Griffiths, Dominik Bettenworth, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Jürgen Schölmerich, Willem Bemelman, Silvio Danese, Jean Yves Mary, David Rubin, Jean-Frederic Colombel, Laurent Peyrin-Biroulet, Iris Dotan, Maria T. Abreu, Axel Dignass. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology 2021; 160(5): 1570 doi: 10.1053/j.gastro.2020.12.031
|
| 3 |
Yoo Min Lee, Eun Sil Kim, Sujin Choi, Hyo-Jeong Jang, Yu Bin Kim, So Yoon Choi, Byung-Ho Choe, Ben Kang. Fecal Calprotectin at Postinduction Is Capable of Predicting Persistent Remission and Endoscopic Healing after 1 Year of Treatment with Infliximab in Pediatric Patients with Crohn’s Disease. Gut and Liver 2024; 18(3): 498 doi: 10.5009/gnl230022
|
| 4 |
Yiyoung Kwon, Yoon Zi Kim, Yon Ho Choe, Mi Jin Kim. Increased monocyte abundance as a marker for relapse after discontinuation of biologics in inflammatory bowel disease with deep remission. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.996875
|
| 5 |
Elana B. Mitchel, Joel R. Rosh. Pediatric Management of Crohn’s Disease. Gastroenterology Clinics of North America 2022; 51(2): 401 doi: 10.1016/j.gtc.2021.12.013
|
| 6 |
Mohammed Al-Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy, Reem Elbeltagi. Fecal calprotectin in pediatric gastrointestinal diseases: Pros and cons. World Journal of Clinical Pediatrics 2024; 13(2): 93341 doi: 10.5409/wjcp.v13.i2.93341
|
| 7 |
Carmen Ribes Koninckx, Ester Donat, Marc A. Benninga, Ilse J. Broekaert, Frederic Gottrand, Kaija‐Leena Kolho, Paolo Lionetti, Erasmo Miele, Rok Orel, Alexandra Papadopoulou, Corina Pienar, Michela G. Schäppi, Michael Wilschanski, Nikhil Thapar. The Use of Fecal Calprotectin Testing in Paediatric Disorders. Journal of Pediatric Gastroenterology and Nutrition 2021; 72(4): 617 doi: 10.1097/MPG.0000000000003046
|
| 8 |
Yeoun Joo Lee, Jae Hong Park. Fecal Calprotectin Assay at an Early Stage of Treatment Can Be Used as a Surrogate Marker to Predict Clinical Remission and Mucosal Healing in Pediatric Crohn’s Disease. Pediatric Gastroenterology, Hepatology & Nutrition 2022; 25(5): 396 doi: 10.5223/pghn.2022.25.5.396
|
| 9 |
Ahmad Albshesh, Alon Abend, Reuma Margalit Yehuda, Hussein Mahajna, Bella Ungar, Shomron Ben-Horin, Uri Kopylov, Dan Carter. Intestinal ultrasound accurately predicts future therapy failure in Crohn’s disease patients in a biologics-induced remission. European Journal of Gastroenterology & Hepatology 2024; doi: 10.1097/MEG.0000000000002883
|
| 10 |
Amy C Porter, Jiri Aubrecht, Chandler Birch, Jonathan Braun, Carolyn Cuff, Suryasarathi Dasgupta, Jeremy D Gale, Robert Hinton, Steven C Hoffmann, Gerard Honig, Bryan Linggi, Marco Schito, Niels Vande Casteele, John-Michael Sauer. Biomarkers of Crohn’s Disease to Support the Development of New Therapeutic Interventions. Inflammatory Bowel Diseases 2020; 26(10): 1498 doi: 10.1093/ibd/izaa215
|
| 11 |
Benjamin Click, Miguel Regueiro. Pediatric Inflammatory Bowel Disease. 2023; : 597 doi: 10.1007/978-3-031-14744-9_42
|
| 12 |
Giulia D’Arcangelo, Marina Aloi. Treat-to-Target in Pediatric Inflammatory Bowel Disease: What Does the Evidence Say?. Pediatric Drugs 2020; 22(5): 463 doi: 10.1007/s40272-020-00406-2
|
| 13 |
Way Seah Lee, Katsuhiro Arai, George Alex, Suporn Treepongkaruna, Kyung Mo Kim, Chee Liang Choong, Karen Calixto Mercado, Andy Darma, Anshu Srivastava, Marion M. Aw. Management and monitoring of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group: Surgical management, disease monitoring, and special considerations. Journal of Gastroenterology and Hepatology 2023; 38(4): 510 doi: 10.1111/jgh.16084
|
| 14 |
Tadeusz J. Popiela, Wirginia Krzyściak, Fabio Pilato, Anna Ligęzka, Beata Bystrowska, Karolina Bukowska-Strakova, Paweł Brzegowy, Karthik Muthusamy, Tamas Kozicz. The Assessment of Endovascular Therapies in Ischemic Stroke: Management, Problems and Future Approaches. Journal of Clinical Medicine 2022; 11(7): 1864 doi: 10.3390/jcm11071864
|
| 15 |
Patrick F van Rheenen, Marina Aloi, Amit Assa, Jiri Bronsky, Johanna C Escher, Ulrika L Fagerberg, Marco Gasparetto, Konstantinos Gerasimidis, Anne Griffiths, Paul Henderson, Sibylle Koletzko, Kaija-Leena Kolho, Arie Levine, Johan van Limbergen, Francisco Javier Martin de Carpi, Víctor Manuel Navas-López, Salvatore Oliva, Lissy de Ridder, Richard K Russell, Dror Shouval, Antonino Spinelli, Dan Turner, David Wilson, Eytan Wine, Frank M Ruemmele. The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update. Journal of Crohn's and Colitis 2021; 15(2): 171 doi: 10.1093/ecco-jcc/jjaa161
|
| 16 |
Elena Yu. Diakonova, Aleksandr S. Bekin, Aleksey A. Gusev, Aleksandr S. Potapov, Maksim M. Lohmatov, Aleksandra V. Zvonareva, Mariya A. Golberg, Sergey P. Yatsyk. The effectiveness of two-stage surgical treatment of children with complicated Crohn’s disease. Russian Pediatric Journal 2023; 23(2): 113 doi: 10.46563/1560-9561-2023-26-2-113-117
|
| 17 |
Chenthan Krishnakumar, Ashwin N. Ananthakrishnan, Brendan M. Boyle, Anne M. Griffiths, Neal S. LeLeiko, David R. Mack, James F. Markowitz, Joel R. Rosh, Cary G. Sauer, Thomas D. Walters, Erin Bonkowski, Lee A. Denson, Jeffrey S. Hyams, Subra Kugathasan. Early Change in Fecal Calprotectin Predicts One‐Year Outcome in Children Newly Diagnosed With Ulcerative Colitis. Journal of Pediatric Gastroenterology and Nutrition 2022; 74(1): 72 doi: 10.1097/MPG.0000000000003291
|
| 18 |
Hiroshi Nakase, Motohiro Esaki, Fumihito Hirai, Taku Kobayashi, Katsuyoshi Matsuoka, Minoru Matsuura, Makoto Naganuma, Masayuki Saruta, Kiichiro Tsuchiya, Motoi Uchino, Kenji Watanabe, Tadakazu Hisamatsu, Akira Andoh, Shigeki Bamba, Motohiro Esaki, Mikihiro Fujiya, Kitaro Futami, Keisuke Hata, Fumihito Hirai, Sakiko Hiraoka, Tadakazu Hisamatsu, Ryota Hokari, Shunji Ishihara, Soichiro Ishihara, Michio Itabashi, Yoichi Kakuta, Jun Kato, Shingo Kato, Takehiko Katsurada, Kazuya Kitamura, Kiyonori Kobayashi, Taku Kobayashi, Kazutaka Koganei, Atsuo Maemoto, Toshiyuki Matsui, Takayuki Matsumoto, Katsuyoshi Matsuoka, Minoru Matsuura, Satoshi Motoya, Masakazu Nagahori, Makoto Naganuma, Yuji Naito, Shiro Nakamura, Hiroshi Nakase, Haruhiko Ogata, Kazuichi Okazaki, Hirotake Sakuraba, Masayuki Saruta, Shinichiro Shinzaki, Ken Sugimoto, Akira Sugita, Yasuo Suzuki, Kenichi Takahashi, Tomohisa Takagi, Kento Takenaka, Ken Takeuchi, Kiichiro Tsuchiya, Tomoyuki Tsujikawa, Motoi Uchino, Fumiaki Ueno, Kenji Watanabe, Mamoru Watanabe, Takayuki Yamamoto, Kaoru Yokoyama, Atsushi Yoshida, Naoki Yoshimura. Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021. Journal of Gastroenterology 2023; 58(4): 313 doi: 10.1007/s00535-023-01958-z
|
| 19 |
Steve Halligan, Darren Boone, Lucinda Archer, Tariq Ahmad, Stuart Bloom, Manuel Rodriguez-Justo, Stuart A Taylor, Sue Mallett. Prognostic biomarkers to identify patients likely to develop severe Crohn’s disease: a systematic review. Health Technology Assessment 2021; 25(45): 1 doi: 10.3310/hta25450
|
| 20 |
Eun Sil Kim, Yiyoung Kwon, Yon Ho Choe, Mi Jin Kim. Albumin-to-Globulin Ratio at 1 Year after Anti-Tumor Necrosis Factor α Therapy Can Serve as a Prognostic Biomarker in Pediatric Crohn’s Disease Patients. Gut and Liver 2022; 16(1): 71 doi: 10.5009/gnl20322
|
| 21 |
Paulina Krawiec, Elżbieta Pac-Kożuchowska. Cathelicidin – A Novel Potential Marker of Pediatric Inflammatory Bowel Disease. Journal of Inflammation Research 2021; : 163 doi: 10.2147/JIR.S288742
|
| 22 |
Fabio CISARÒ, Antonio PIZZOL, Caterina RIGAZIO, Pier L. CALVO. Fecal calprotectin in the pediatric population: a 2020 update. Minerva Pediatrica 2021; 72(6) doi: 10.23736/S0026-4946.20.06002-8
|
| 23 |
Joowon Yi, Hanah Kim, Hee-Won Moon, Mina Hur, Yeo-Min Yun. Clinical Utility of Fecal Neutrophil Gelatinase-Associated Lipocalin and Calprotectin as Biomarkers of Clostridioides (Clostridium) difficile Infection. Laboratory Medicine Online 2020; 10(2): 125 doi: 10.3343/lmo.2020.10.2.125
|
| 24 |
Jair Gonzalez Marques, Engy Shokry, Klara Frivolt, Katharina Julia Werkstetter, Annecarin Brückner, Tobias Schwerd, Sibylle Koletzko, Berthold Koletzko. Metabolomic Signatures in Pediatric Crohn’s Disease Patients with Mild or Quiescent Disease Treated with Partial Enteral Nutrition: A Feasibility Study. SLAS Technology 2021; 26(2): 165 doi: 10.1177/2472630320969147
|
| 25 |
Joseph Meredith, Paul Henderson, David C. Wilson, Richard K. Russell. Combination Immunotherapy Use and Withdrawal in Pediatric Inflammatory Bowel Disease—A Review of the Evidence. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.708310
|
| 26 |
Pauline Veyrard, Xavier Roblin, Céline Pansart, Ren Mao, Stéphane Nancey, Martin Killian, Louis Waeckel, Anne-Emmanuelle Berger, Nicolas Williet, Laetitia Bastide, Mathilde Barrau, Quentin Tournier, Stéphane Paul. Serum calprotectin is useful to confirm inflammatory bowel disease activity but not to predict relapse. Clinical Immunology Communications 2022; 2: 33 doi: 10.1016/j.clicom.2022.02.001
|
| 27 |
Tingpeng Hu, Wei Wang, Fusheng Song, Wenguang Zhang, Jun Yang. Fecal Calprotectin in Predicting Relapse of Inflammatory Bowel Disease in Children and Adolescents: A Meta-Analysis and Systematic Review. Pediatric Annals 2023; 52(9) doi: 10.3928/19382359-20230720-04
|